SEARCH RESULTS for assignee:"BIOGEN IDEC MA INC."

Showing 1 to 19 of 19 results

Share this

Reel/Frame

Last Update:

Patent(s)

(X0) 12301988: METHODS OF TREATING STROKE AND TRAUMATIC BRAIN INJURY USING HUMANIZED AQC2 ANTI-VLA-1 ANTIBODIES

(A1) 20100233159: METHODS OF TREATING STROKE AND TRAUMATIC BRAIN INJURY USING HUMANIZED AQC2 ANTI-VLA-1 ANTIBODIES

(B2) 1: METHODS OF TREATING STROKE AND TRAUMATIC BRAIN INJURY USING HUMANIZED AQC2 ANTI-VLA-1 ANTIBODIES

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15596468: METHODS OF TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES WITH NATALIZUMAB

(A1) 20170247457: METHODS OF TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES WITH NATALIZUMAB

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15621665: HETEROBICYCLIC SPHINGOSINE 1-PHOSPHATE ANALOGS

(A1) 20180002356: HETEROBICYCLIC SPHINGOSINE 1-PHOSPHATE ANALOGS

(B2) 1: HETEROBICYCLIC SPHINGOSINE 1-PHOSPHATE ANALOGS

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 14589372: ANTI-NEUBLASTIN ANTIBODIES AND USES THEREOF

(A1) 20150344550: ANTI-NEUBLASTIN ANTIBODIES AND USES THEREOF

(B2) 1: ANTI-NEUBLASTIN ANTIBODIES AND USES THEREOF

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 14416214: Blood Factor Monitoring Assay and Uses Thereof

(A1) 20150185235: Blood Factor Monitoring Assay and Uses Thereof

(B2) 1: Blood Factor Monitoring Assay and Uses Thereof

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15055910: HETEROCYCLIC TYROSINE KINASE INHIBITORS

(A1) 20170027956: HETEROCYCLIC TYROSINE KINASE INHIBITORS

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15783809: BICYCLIC ARYL SPHINGOSINE 1-PHOSPHATE ANALOGS

(A1) 20180133233: BICYCLIC ARYL SPHINGOSINE 1-PHOSPHATE ANALOGS

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15101756: POPULATION PHARMACOKINETICS TOOLS AND USES THEREOF

(A1) 20160306945: POPULATION PHARMACOKINETICS TOOLS AND USES THEREOF

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15705454: LINGO-2 ANTAGONISTS FOR TREATMENT OF CONDITIONS INVOLVING MOTOR NEURONS

(A1) 20180111994: LINGO-2 ANTAGONISTS FOR TREATMENT OF CONDITIONS INVOLVING MOTOR NEURONS

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15196389: PYRIMIDINYL TYROSINE KINASE INHIBITORS

(A1) 20160304494: PYRIMIDINYL TYROSINE KINASE INHIBITORS

(B2) 9: PYRIMIDINYL TYROSINE KINASE INHIBITORS

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15698171: BRUTON'S TYROSINE KINASE INHIBITORS

(A1) 20180065974: BRUTON'S TYROSINE KINASE INHIBITORS

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 14021547: METHOD FOR THE TREATMENT OF INFLAMMATORY DISORDERS

(A1) 20140154259: METHOD FOR THE TREATMENT OF INFLAMMATORY DISORDERS

(B2) 9: METHOD FOR THE TREATMENT OF INFLAMMATORY DISORDERS

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15644029: Neuroprotection in Demyelinating Diseases

(A1) 20180021288: Neuroprotection in Demyelinating Diseases

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15644029: Neuroprotection in Demyelinating Diseases

(A1) 20180021288: Neuroprotection in Demyelinating Diseases

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(B2) 9: SUBSTITUTED PYRIMIDINES FOR INHIBITING RAF KINASE ACTIVITY

(X0) 15380515: SUBSTITUTED PYRIMIDINES FOR INHIBITING RAF KINASE ACTIVITY

(A1) 20170158686: SUBSTITUTED PYRIMIDINES FOR INHIBITING RAF KINASE ACTIVITY

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15397421: BICYCLIC ARYL SPHINGOSINE 1-PHOSPHATE ANALOGS

(A1) 20170239280: BICYCLIC ARYL SPHINGOSINE 1-PHOSPHATE ANALOGS

(B2) 9: BICYCLIC ARYL SPHINGOSINE 1-PHOSPHATE ANALOGS

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 14328256: METHODS OF TREATMENT USING PYRIDINONYL PDK1 INHIBITORS

(A1) 20150018351: METHODS OF TREATMENT USING PYRIDINONYL PDK1 INHIBITORS

(B2) 9: METHODS OF TREATMENT USING PYRIDINONYL PDK1 INHIBITORS

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 14213180: Factor VIII Polypeptide Formulations

(A1) 20140308280: Factor VIII Polypeptide Formulations

(B2) 9: Factor VIII Polypeptide Formulations

Assignee(s)